AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

FLUCYTOSINE

18 registrations across 8 African markets— 16 active

Markets with FLUCYTOSINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
FLUCYTOSINE TABLETS 500MG
TABLETS
🇷🇼RwandaMacleods Pharmaceuticals LimitedactiveSept 2029
OTYCULF 500
TABLET; ORAL
🇿🇼ZimbabweMYLAN LABORATORIES LIMITED [OTL]activeJan 2029
OTYCULF 250
TABLET; ORAL
🇿🇼ZimbabweMYLAN LABORATORIES LIMITED [OTL]activeJan 2029
FLUCYTOSINE
TABLET, COATED; ORAL
🇿🇼ZimbabweMACLEODS PHARMACEUTICALS LIMITEDactiveDec 2027
Emzor Flucytosine 250 Tablet
Tablet
🇳🇬NigeriaEmzor Pharmaceutical Industries LimitedactiveMar 2026
OTYCULF 250MG TABLET
TABLET
🇲🇼MalawiexpiredMar 2025
OTYCULF 500MG TABLET
TABLET
🇲🇼MalawiexpiredMar 2025
ANCOMYL 500 mg🇿🇦South AfricaViatris Healthcare (Pty) LtdactiveJan 1900
ANCOMYL 250 mg🇿🇦South AfricaViatris Healthcare (Pty) LtdactiveJan 1900
CANDOBON 250 mg🇿🇦South AfricaViatris Healthcare (Pty) LtdactiveJan 1900
CANDOBON 500 mg🇿🇦South AfricaViatris Healthcare (Pty) LtdactiveJan 1900
Flucytosine Tablet 500mg
Tablet
🌍WWMacleods Pharmaceuticals Ltdactive
Flucytosine Tablet 500mg
Tablet
🌍WWMylan Laboratories Ltd.active
ANCOTIL
SOLUTION POUR PERFUSION
🇲🇦Moroccoactive
Flucytosine🌍WWSolara Active Pharma Sciences Limitedactive
OTYCULF
Tablets
🇹🇿TanzaniaMylan Laboratories Limitedactive
OTYCULF 250
Tablets
🇹🇿TanzaniaMylan Laboratories Limitedactive
Flucytosine Tablets 500 mg
Oral tablet
🇹🇿TanzaniaMacleods Pharmaceuticals Limitedactive

FLUCYTOSINE in Africa — Regulatory Overview

FLUCYTOSINE is registered across 8 African markets with 18 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Zimbabwe, Tanzania, WW and 4 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 18 registrations, 16 (89%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.